PTPRK
Basic information
Region (hg38): 6:127968785-128520616
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PTPRK gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 53 | 54 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 53 | 1 | 3 |
Variants in PTPRK
This is a list of pathogenic ClinVar variants found in the PTPRK region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-127973023-G-A | not specified | Uncertain significance (Jul 08, 2022) | ||
6-127973095-C-T | Hereditary breast ovarian cancer syndrome | Uncertain significance (Aug 01, 2020) | ||
6-127973096-G-A | not specified | Uncertain significance (Jul 05, 2023) | ||
6-127973105-T-C | not specified | Uncertain significance (Mar 06, 2023) | ||
6-127973114-C-T | not specified | Uncertain significance (Mar 07, 2024) | ||
6-127973116-A-T | not specified | Uncertain significance (Nov 02, 2023) | ||
6-127973802-T-C | not specified | Uncertain significance (Feb 12, 2024) | ||
6-127981127-C-T | not specified | Uncertain significance (Feb 17, 2022) | ||
6-127981205-T-C | not specified | Uncertain significance (Mar 01, 2024) | ||
6-127981210-C-T | not specified | Uncertain significance (Sep 29, 2023) | ||
6-127981265-G-C | not specified | Uncertain significance (Jan 26, 2023) | ||
6-127981272-G-C | Benign (May 24, 2018) | |||
6-127982883-A-G | Uncertain significance (Mar 01, 2022) | |||
6-127982886-T-C | not specified | Uncertain significance (Apr 24, 2024) | ||
6-127983262-T-C | not specified | Uncertain significance (Jun 19, 2024) | ||
6-127983267-C-T | not specified | Uncertain significance (Jul 13, 2022) | ||
6-127983268-G-A | not specified | Uncertain significance (May 30, 2024) | ||
6-127985832-G-A | not specified | Uncertain significance (Oct 30, 2023) | ||
6-127985856-C-T | not specified | Uncertain significance (Dec 22, 2023) | ||
6-127990849-C-T | not specified | Uncertain significance (Jun 09, 2022) | ||
6-127998845-A-G | not specified | Uncertain significance (Aug 17, 2022) | ||
6-127998871-C-T | not specified | Uncertain significance (May 18, 2023) | ||
6-127998874-C-A | not specified | Uncertain significance (Nov 18, 2023) | ||
6-128005125-A-G | not specified | Uncertain significance (Nov 07, 2022) | ||
6-128005131-T-A | not specified | Uncertain significance (Sep 15, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PTPRK | protein_coding | protein_coding | ENST00000368213 | 31 | 551947 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.903 | 0.0971 | 125694 | 1 | 53 | 125748 | 0.000215 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.17 | 551 | 804 | 0.685 | 0.0000428 | 9473 |
Missense in Polyphen | 219 | 404.06 | 0.542 | 4897 | ||
Synonymous | -0.272 | 294 | 288 | 1.02 | 0.0000160 | 2755 |
Loss of Function | 6.68 | 17 | 82.5 | 0.206 | 0.00000472 | 920 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00162 | 0.00162 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000142 | 0.000141 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000132 | 0.000131 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Regulation of processes involving cell contact and adhesion such as growth control, tumor invasion, and metastasis. Negative regulator of EGFR signaling pathway. Forms complexes with beta-catenin and gamma-catenin/plakoglobin. Beta-catenin may be a substrate for the catalytic activity of PTPRK/PTP-kappa. {ECO:0000269|PubMed:19836242}.;
- Pathway
- Signal Transduction;EGFR downregulation;Signaling by EGFR;EGFR1;Signaling by Receptor Tyrosine Kinases;Calcineurin-regulated NFAT-dependent transcription in lymphocytes
(Consensus)
Intolerance Scores
- loftool
- 0.665
- rvis_EVS
- -1.72
- rvis_percentile_EVS
- 2.47
Haploinsufficiency Scores
- pHI
- 0.395
- hipred
- Y
- hipred_score
- 0.694
- ghis
- 0.561
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.654
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ptprk
- Phenotype
Gene ontology
- Biological process
- protein dephosphorylation;cell adhesion;signal transduction;transforming growth factor beta receptor signaling pathway;negative regulation of cell population proliferation;negative regulation of keratinocyte proliferation;cell migration;negative regulation of cell migration;neuron projection development;protein localization to cell surface;cellular response to reactive oxygen species;cellular response to UV;peptidyl-tyrosine dephosphorylation;negative regulation of cell cycle;negative regulation of transcription, DNA-templated;focal adhesion assembly
- Cellular component
- photoreceptor outer segment;plasma membrane;integral component of plasma membrane;cell-cell junction;adherens junction;cell surface;integral component of membrane;cell junction;axon;dendrite;leading edge membrane;neuronal cell body;intracellular membrane-bounded organelle
- Molecular function
- protein tyrosine phosphatase activity;transmembrane receptor protein tyrosine phosphatase activity;protein binding;beta-catenin binding;protein kinase binding;gamma-catenin binding